
AstraZeneca has withdrawn its Covid-19 vaccine from the market due to a “surplus” of new jabs that can target new variants of the virus.
The pharmaceutical giant said the availability of vaccines that were more effective against new strains of the virus had led to a decline in demand for the original jab.